| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1601-5215.2003.00049.X |
| P698 | PubMed publication ID | 26983769 |
| P50 | author | Eduard Vieta | Q20090640 |
| P2093 | author name string | B Corbella | |
| P2860 | cites work | Cloning and characterization of a mammalian lithium-sensitive bisphosphate 3'-nucleotidase inhibited by inositol 1,4-bisphosphate | Q22009472 |
| Antidepressant and circadian phase-shifting effects of light | Q22299407 | ||
| GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis | Q24309150 | ||
| Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin | Q24313571 | ||
| Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure | Q24562986 | ||
| A molecular mechanism for the effect of lithium on development | Q24629067 | ||
| Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy | Q27637498 | ||
| Crystallographic evidence for the action of potassium, thallium, and lithium ions on fructose-1,6-bisphosphatase | Q27729690 | ||
| Crystal structure of inositol polyphosphate 1-phosphatase at 2.3-A resolution | Q27730735 | ||
| Structural studies of metal binding by inositol monophosphatase: evidence for two-metal ion catalysis | Q27730870 | ||
| A salt-sensitive 3'(2'),5'-bisphosphate nucleotidase involved in sulfate activation | Q27933490 | ||
| Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction | Q28131789 | ||
| Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation | Q28140761 | ||
| Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain | Q28141275 | ||
| Control of transcription factors by signal transduction pathways: the beginning of the end | Q28209088 | ||
| The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation | Q28244304 | ||
| Neural and developmental actions of lithium: a unifying hypothesis | Q28254375 | ||
| Emergent properties of networks of biological signaling pathways | Q28293858 | ||
| Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants | Q28326442 | ||
| Analysis of the convulsant-potentiating effects of lithium in rats | Q28326990 | ||
| Potentiation of malaoxon-induced convulsions by lithium: early neuronal injury, phosphoinositide signaling, and calcium | Q28335526 | ||
| Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog | Q28342327 | ||
| Effect of lithium on tachykinins, calcitonin gene-related peptide, and neuropeptide Y in rat brain | Q48955715 | ||
| Activation of the Wnt signaling pathway: a molecular mechanism for lithium action | Q48958687 | ||
| Regular 48-hour cycling of sleep duration and mood in a 35-year-old woman: use of lithium in time isolation | Q49014011 | ||
| Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity | Q49016525 | ||
| Effects of lithium carbonate on methylphenidate-induced mood, behavior, and cognitive processes. | Q51262013 | ||
| A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. | Q52023319 | ||
| Hyperfunctional G proteins in mononuclear leukocytes of patients with mania. | Q52052203 | ||
| Lithium therapy and signal transduction. | Q52171133 | ||
| Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. | Q53199978 | ||
| Comparison of acute and chronic lithium treatment on 3H-norepinephrine uptake by rat brain slices. | Q54259005 | ||
| Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression. | Q54368435 | ||
| Mood stabilizers have differential effects on endogenous ADP ribosylation in C6 glioma cells. | Q55479349 | ||
| Pro-opiomelanocortin-related peptides in cerebrospinal fluid: A study of manic-depressive disorder | Q57268961 | ||
| [20] Analysis of altered gene expression by differential display | Q58883576 | ||
| Antiaversive properties of opioids in the conditioned taste aversion test in the rat. | Q42100485 | ||
| Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia | Q42226216 | ||
| Effect of chronic lithium on cholinergically mediated responses and [3H]QNB binding in rat brain | Q42229123 | ||
| Effect of low-dose lithium administration and subsequent withdrawal on biogenic amines in rat brain | Q42232690 | ||
| Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects | Q42437441 | ||
| The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects | Q42462481 | ||
| Alteration in the regulation of neuronal muscarinic acetylcholine receptor number induced by chronic lithium in neuroblastoma cells | Q42501634 | ||
| Effects of chronic lithium treatment on serotonin binding sites in rat brain | Q43586009 | ||
| Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers | Q43594287 | ||
| Effect of Li+ upon the Mg2+-dependent activation of recombinant Gialpha1. | Q43613595 | ||
| Lithium-Sensitive Production of Inositol Phosphates During Amphibian Embryonic Mesoderm Induction | Q43688434 | ||
| Tetraspan protein CD151: a common target of mood stabilizing drugs? | Q43781213 | ||
| Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites | Q43858813 | ||
| Iontophoresis of lithium antagonizes noradrenergic action on prefrontal neurons of the rat. | Q44080764 | ||
| Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression | Q44133502 | ||
| Stimulation of hypothalamic opioid peptide release by lithium is mediated by opioid autoreceptors: evidence from a combined in vitro, ex vivo study | Q44338534 | ||
| Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. | Q44343686 | ||
| Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning | Q44346240 | ||
| Activation of protein kinase C alters the interaction of alpha 2-adrenoceptors and the inhibitory GTP-binding protein (Gi) in human platelets | Q44755108 | ||
| The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects | Q45134248 | ||
| Spatial expression of the Drosophila segment polarity gene armadillo is posttranscriptionally regulated by wingless | Q45247642 | ||
| Interactions among lithium, calcium, diacylglycerides, and phorbol esters in the regulation of adrenocorticotropin hormone release from AtT-20 cells | Q46171516 | ||
| Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase | Q46680546 | ||
| Lithium stimulates gene expression through the AP-1 transcription factor pathway | Q47759848 | ||
| Lithium regulation of aldolase A expression in the rat frontal cortex: identification by differential display | Q47842223 | ||
| Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. | Q47877188 | ||
| A novel target of lithium therapy | Q47884637 | ||
| Circadian rhythms. New cogwheels in the clockworks | Q47924272 | ||
| Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex | Q48112918 | ||
| Brain G-protein proteolysis by calpain: enhancement by lithium | Q48174770 | ||
| Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets | Q48208353 | ||
| Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression | Q48208784 | ||
| Influence of the pineal gland on pituitary function in humans | Q48229127 | ||
| Short-term lithium treatment enhances responsiveness of postsynaptic 5-HT1A receptors without altering 5-HT autoreceptor sensitivity: an electrophysiological study in the rat brain | Q48258835 | ||
| Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding | Q48277664 | ||
| Valproate robustly enhances AP-1 mediated gene expression | Q48305334 | ||
| Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. | Q48394153 | ||
| Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase | Q48406074 | ||
| Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions | Q48474283 | ||
| Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats | Q48532736 | ||
| Chronic lithium administration alters a prominent PKC substrate in rat hippocampus | Q48546705 | ||
| Combined lithium and valproate treatment and subsequent withdrawal: serotonergic mechanism of their interaction in discrete brain regions | Q48561312 | ||
| Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons | Q48658321 | ||
| Subgenual prefrontal cortex abnormalities in mood disorders | Q48725544 | ||
| Increase in AP-1 transcription factor DNA binding activity by valproic acid | Q48773462 | ||
| Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex | Q48793249 | ||
| Chronic lithium treatment prevents atropine-induced supersensitivity of the muscarinic phosphoinositide response in rat hippocampus | Q48889521 | ||
| Enhanced protein kinase C activity and translocation in bipolar affective disorder brains | Q48907362 | ||
| Li+/Mg2+ competition at therapeutic intracellular Li+ levels in human neuroblastoma SH-SY5Y cells | Q48947878 | ||
| Effect of LiCl pretreatment on cholinomimetic-induced seizures and seizure-induced brain edema in rats | Q48949943 | ||
| Intracerebroventricular antisense to inositol monophosphatase-1 reduces enzyme activity but does not affect Li-sensitive behavior | Q28566390 | ||
| The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS | Q28570728 | ||
| Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain | Q28575972 | ||
| A novel mammalian lithium-sensitive enzyme with a dual enzymatic activity, 3'-phosphoadenosine 5'-phosphate phosphatase and inositol-polyphosphate 1-phosphatase | Q28583454 | ||
| WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons | Q28586422 | ||
| Wnt signaling: a common theme in animal development | Q29547527 | ||
| Inositol phosphates and cell signalling | Q29615042 | ||
| Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells | Q29618245 | ||
| Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C | Q29620247 | ||
| Lithium stimulation of HPP-CFC and stromal growth factor production in murine Dexter culture | Q30436037 | ||
| New insights into the role and mechanism of glycogen synthase activation by insulin | Q30470182 | ||
| Designing small-molecule switches for protein-protein interactions | Q30880060 | ||
| Anti-bipolar therapy: mechanism of action of lithium | Q33596950 | ||
| Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge | Q33750436 | ||
| Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness | Q33782621 | ||
| Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. | Q33796802 | ||
| Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness | Q33809252 | ||
| Complexity in biological signaling systems | Q33844786 | ||
| Lithium evokes expression of vegetal-specific molecules in the animal blastomeres of sea urchin embryos | Q33857336 | ||
| Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells | Q33924323 | ||
| Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation. | Q33957378 | ||
| Regulation of glycogen synthase kinase 3beta and downstream Wnt signaling by axin | Q33959834 | ||
| A molecular and cellular theory of depression | Q34064955 | ||
| Neuroplasticity and cellular resilience in mood disorders | Q34111006 | ||
| A common mechanism of action for three mood-stabilizing drugs | Q34128871 | ||
| Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo | Q34183479 | ||
| Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies | Q34185330 | ||
| Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder | Q34185366 | ||
| Lithium and synaptic plasticity. | Q34185371 | ||
| Molecular targets of lithium action | Q34192797 | ||
| Lithium-related genetics of bipolar disorder | Q34281207 | ||
| In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330. | Q34355076 | ||
| Alternate energy coupling of ArsB, the membrane subunit of the Ars anion-translocating ATPase | Q34413287 | ||
| Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx | Q34458296 | ||
| Lithium treatment at 52. | Q34547096 | ||
| Glycogen synthase kinase 3: an emerging therapeutic target | Q34552674 | ||
| PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers | Q34622380 | ||
| Neuroprotective effects of lithium in cultured cells and animal models of diseases. | Q34692758 | ||
| Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? | Q34714351 | ||
| Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders? | Q34726336 | ||
| Initiation and adaptation: a paradigm for understanding psychotropic drug action | Q34732299 | ||
| Mood stabilizer combinations: a review of safety and efficacy | Q34744469 | ||
| Inositol Lipids and Signal Transduction in the Nervous System: An Update | Q35224675 | ||
| G proteins: implications for psychiatry | Q35255728 | ||
| Toward a crystal-clear view of lithium's site of action. | Q35529747 | ||
| A cell-free assay system for beta-catenin signaling that recapitulates direct inductive events in the early xenopus laevis embryo | Q36326068 | ||
| Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex | Q37632156 | ||
| Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes | Q37720646 | ||
| Lithium and serotonin function: implications for the serotonin hypothesis of depression | Q38138445 | ||
| The mechanism of protein kinase C activation | Q38208888 | ||
| GTP-binding proteins as possible targets for protein kinase C action | Q38240180 | ||
| Signal transmission by the insulin-like growth factors | Q38297337 | ||
| Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity | Q38336655 | ||
| Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium | Q38364991 | ||
| Tol1, a fission yeast phosphomonoesterase, is an in vivo target of lithium, and its deletion leads to sulfite auxotrophy | Q39499902 | ||
| Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans | Q39975414 | ||
| Signal transduction pathways. Molecular targets for lithium's actions | Q40437069 | ||
| Lithium in the treatment of mood disorders | Q40681257 | ||
| Lithium and brain signal transduction systems | Q40719294 | ||
| Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations. | Q40808111 | ||
| Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C. | Q40888981 | ||
| Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol | Q40925779 | ||
| Regulation of the protein kinase activity of Shaggy(Zeste-white3) by components of the wingless pathway in Drosophila cells and embryos | Q40939820 | ||
| Evidence that a proconvulsant action of lithium is mediated by inhibition of myo-inositol phosphatase in mouse brain | Q41131004 | ||
| Lithium increases 5-HT-mediated prolactin release. | Q41262711 | ||
| Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. | Q41423732 | ||
| Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate | Q41571807 | ||
| Effects of lithium therapy on mao in manic-depressive illness | Q41601144 | ||
| Lithium delays biochemical circadian rhythms in rats | Q41601466 | ||
| Effect of secretagogues on components of the secretory system in AtT-20 cells | Q41746912 | ||
| Effects of lithium and insulin on glycogen synthesis in L6 myocytes: additive effects on inactivation of glycogen synthase kinase-3. | Q41750681 | ||
| Alterations in G-protein expression and the hormonal regulation of adenylate cyclase in the adipocytes of obese (fa/fa) Zucker rats | Q41905840 | ||
| Effect of short- and long-term administration of lithium on the release of endogenous 5-HT in the hippocampus of the rat in vivo and in vitro | Q41953702 | ||
| Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices | Q42008702 | ||
| In Vivo Evidence that Lithium Inactivates Gi Modulation of Adenylate Cyclase in Brain | Q42013568 | ||
| P433 | issue | 06 | |
| P304 | page(s) | 316-340 | |
| P577 | publication date | 2003-12-01 | |
| P1433 | published in | Acta Neuropsychiatrica | Q4676734 |
| P1476 | title | Molecular targets of lithium action | |
| P478 | volume | 15 |
| Q60922281 | A Dynamical Bifurcation Model of Bipolar Disorder Based on Learned Expectation and Asymmetry in Mood Sensitivity |
| Q33284843 | A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? |
| Q38846631 | Antiviral effect of lithium chloride on feline calicivirus in vitro |
| Q92404899 | Dopamine D3 receptor and GSK3β signaling mediate deficits in novel object recognition memory within dopamine transporter knockdown mice |
| Q46255549 | Outer dense fibers stabilize the axoneme to maintain sperm motility. |
| Q37219221 | Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study |
| Q48397787 | Restraint stress influences AP-1 and CREB DNA-binding activity induced by chronic lithium treatment in the rat frontal cortex and hippocampus |
| Q37665567 | Treatment of psychotic symptoms in bipolar disorder with aripiprazole monotherapy: a meta-analysis |
| Q61775436 | Vigencia del tratamiento con litio |
Search more.